Wednesday, January 7, 2009

MiddleBrook Pharmaceuticals to Launch Moxatag March 2009

MiddleBrook Pharmaceuticals, Inc. , today announced that the professional launch of Moxatag (amoxicillin extended-release) Tablets, 775mg, will begin on March 16, 2009. The Company has hired over half of its 270-person field force which will promote Moxatag, the first and only FDA-approved once-daily amoxicillin, to health care professionals nationwide. Moxatag is approved for the treatment of adults and pediatric patients 12 years and older with tonsillitis and/or pharyngitis.

The details can be read here.

No comments: